Montag & Associates’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$527K Hold
6,825
0.02% 299
2025
Q4
$441K Sell
6,825
-1,870
-22% -$115K 0.02% 312
2025
Q3
$556K Sell
8,695
-442
-5% -$30.9K 0.03% 296
2025
Q2
$690K Hold
9,137
0.03% 277
2025
Q1
$813K Hold
9,137
0.04% 260
2024
Q4
$842K Sell
9,137
-1,425
-13% -$146K 0.04% 260
2024
Q3
$1.19M Hold
10,562
0.06% 231
2024
Q2
$1.04M Hold
10,562
0.05% 222
2024
Q1
$1.07M Buy
10,562
+162
+2% +$14.2K 0.05% 237
2023
Q4
$943K Sell
10,400
-850
-8% -$67.7K 0.05% 234
2023
Q3
$873K Sell
11,250
-850
-7% -$70.5K 0.06% 232
2023
Q2
$1.02M Sell
12,100
-1,175
-9% -$95.5K 0.06% 210
2023
Q1
$1.13M Sell
13,275
-2,500
-16% -$215K 0.07% 194
2022
Q4
$1.3M Hold
15,775
0.09% 180
2022
Q3
$1.13M Buy
15,775
+300
+2% +$27K 0.08% 188
2022
Q2
$1.4M Hold
15,475
0.09% 180
2022
Q1
$1.73M Hold
15,475
0.09% 181
2021
Q4
$1.87M Sell
15,475
-1,175
-7% -$131K 0.09% 180
2021
Q3
$1.68M Hold
16,650
0.09% 180
2021
Q2
$1.94M Hold
16,650
0.1% 174
2021
Q1
$1.83M Hold
16,650
0.1% 173
2020
Q4
$1.67M Sell
16,650
-9,075
-35% -$841K 0.1% 168
2020
Q3
$2.01M Buy
25,725
+250
+1% +$18.8K 0.16% 130
2020
Q2
$1.77M Sell
25,475
-3,200
-11% -$202K 0.16% 129
2020
Q1
$1.34M Sell
28,675
-475
-2% -$30.5K 0.13% 140
2019
Q4
$2.31M Sell
29,150
-150
-0.5% -$11.5K 0.18% 119
2019
Q3
$2.16M Sell
29,300
-3,800
-11% -$273K 0.19% 113
2019
Q2
$2.58M Sell
33,100
-100
-0.3% -$7.6K 0.23% 103
2019
Q1
$2.52M Buy
33,200
+250
+0.8% +$19.9K 0.23% 106
2018
Q4
$2.41M Sell
32,950
-4,000
-11% -$319K 0.26% 95
2018
Q3
$3.54M Sell
36,950
-100
-0.3% -$9.91K 0.31% 81
2018
Q2
$3.7M Hold
37,050
0.38% 71
2018
Q1
$3.91M Hold
37,050
0.4% 70
2017
Q4
$3.43M Hold
37,050
0.33% 90
2017
Q3
$3.35M Buy
37,050
+3,000
+9% +$255K 0.36% 84
2017
Q2
$2.86M Buy
34,050
+1,875
+6% +$151K 0.32% 91
2017
Q1
$2.6M Buy
32,175
+815
+3% +$64.1K 0.29% 97
2016
Q4
$2.36M Buy
31,360
+6,700
+27% +$484K 0.28% 98
2016
Q3
$1.67M Sell
24,660
-8,250
-25% -$554K 0.21% 122
2016
Q2
$2.23M Buy
32,910
+300
+0.9% +$22K 0.3% 103
2016
Q1
$2.35M Sell
32,610
-575
-2% -$37.7K 0.33% 91
2015
Q4
$2.24M Sell
33,185
-1,900
-5% -$133K 0.33% 91
2015
Q3
$2.27M Sell
35,085
-30,300
-46% -$2.24M 0.36% 91
2015
Q2
$5.35M Buy
65,385
+36,350
+125% +$2.8M 0.78% 42
2015
Q1
$2.01M Sell
29,035
-4,000
-12% -$289K 0.29% 107
2014
Q4
$2.51M Buy
+33,035
New +$2.61M 0.38% 89

Other funds holding EMN

Montag & Associates's EMN Position: Q1 2026 in Review

Montag & Associates held its Eastman Chemical (EMN) position steady in Q1 2026 at 6,825 shares worth $527K. The position accounts for 0.02% of the portfolio, ranked #299.

Montag & Associates first reported a position in EMN in Q4 2014 and has held it in 46 quarters since. The position peaked at $5.35M in Q2 2015. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Montag & Associates held 6,825 shares of Eastman Chemical worth $527K as of Q1 2026.
  • Montag & Associates left its Eastman Chemical share count unchanged in Q1 2026.
  • Eastman Chemical made up 0.02% of Montag & Associates's portfolio in Q1 2026, its #299 holding.
  • Montag & Associates first reported a position in Eastman Chemical in Q4 2014 and has held it in 46 quarters since.
  • Montag & Associates's Eastman Chemical position peaked at $5.35M in Q2 2015.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.